Chemoradiation in Nasopharyngeal Carcinoma: A 6-Year Experience in Tehran Cancer Institute
To determine the addition of value of neoadjuvant, concurrent and adjuvant chemotherapy to radiation in the treatment of nasopharyngeal carcinoma with regard to the overall survival (OS) and disease free survival (DFS) within a six year period in Tehran cancer institute. Files of all patients with n...
Main Authors: | Bita Kalaghchi, Ali Kazemian, Farnaz Amouzegar Hashemi, Mehdi Aghili, Farshid Farhan, Peiman Haddad |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2011-01-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | http://journals.tums.ac.ir/upload_files/pdf/17752.pdf |
Similar Items
-
Chemoradiation in Nasopharyngeal Carcinoma: A 6-Year Experience in Tehran Cancer Institute
by: Bita Kalaghchi, et al.
Published: (2011-01-01) -
Treatment Results and Epidemiologic Factors in Oral Tongue Cancer: Analysis of 110 Patients in Cancer Institute of Tehran
by: Farnaz Amouzegar hashemi, et al.
Published: (2011-02-01) -
External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma
by: Pui-Lam Yip, et al.
Published: (2021-08-01) -
The comparison between effect of chemoradiation with weekly cisplatin with or without celecoxib in treatment of nasopharyngeal carcinoma: A phase III clinical trial
by: Mohamad Mohammadianpanah, et al.
Published: (2009-07-01) -
Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis
by: Lei Wang, et al.
Published: (2020-07-01)